Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

Two monoclonal antibodies appeared safe and tolerable when administered alone or in combination to newborns exposed to HIV, according to a proof-of-concept study presented at the International AIDS ...

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

Scientists, researchers, policy makers and HIV/AIDS advocates at a meeting in Kigali, Rwanda, from July 13-17 for the 13th ...

For more than two decades, the global community has united to fight the HIV pandemic, achieving remarkable progress. New HIV transmissions and AIDS-related deaths have dropped significantly, and ...

The International AIDS Society has announced the 2022 International AIDS Conference will take place in-person in Montreal. The conference, which will also feature virtual events, is scheduled to take ...

At a news conference last week, International AIDS Society President Sharon Lewin cautioned against using the word “cure. ...